Researchers in Singapore have come up with a new treatment that may put an end to taking daily medication for glaucoma.
The Ocular Therapeutic Engineering Centre (OTEC) team, from the Nanyang Technological University in Singapore, has developed LipoLat, a new treatment that is simple, quick, and painless. It involves an injection into the conjunctiva, four times a year, of a solution containing an anti-glaucoma drug wrapped in nano-sized capsules. The nano-capsule then slowly releases the drug over a number of weeks, maintaining a sufficient dose in the organism.
A human clinical trial is presently underway. Up to now, preclinical studies have shown that a single injection is as equally effective as three months of daily eye drops. This treatment is also a way around many problems that come with eye drops, including allergies, unpleasant side effects, remembering to take them at the correct time and correct insertion technique.
Source: http://www.bulletins-electroniques.com/actualites/72873.htm
